Literature DB >> 20082143

Aberrant synthesis of ATP synthase resulting from a novel deletion in mitochondrial DNA in an African patient with progressive external ophthalmoplegia.

Francois H van der Westhuizen1, Joél Smet, Oksana Levanets, Madelein Meissner-Roloff, Roan Louw, Rudy Van Coster, Izelle Smuts.   

Abstract

A young, adult, African male patient presented with progressive proximal muscle weakness, external ophthalmoplegia and ptosis, as well as cardiac conduction abnormalities resembling Kearns-Sayre syndrome (KSS). Magnetic resonance imaging (MRI) of the brain revealed normal basal ganglia but bilateral well-circumscribed lesions in the cerebellar peduncles. Enzyme deficiencies in oxidative phosphorylation (OXPHOS) complexes I, IV and V was measured in muscle tissue. Blue native polyacrylamide gel electrophoresis (BN-PAGE) confirmed decreased protein content and activity of these complexes and revealed the presence of two catalytically active complex V sub-complexes. Upon investigation by molecular genetics, the mitochondrial DNA (mtDNA) copy number was found to be elevated and a novel deletion of 3431 bp was found in 80% of muscle mtDNA between positions 7115 and 10546, flanked by a 5 bp direct repeat sequence. In addition, it could also be concluded that the absence of mtDNA-encoded ATPase6 and ATPase8 genes in this patient clearly resulted in aberrant synthesis of ATP synthase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20082143     DOI: 10.1007/s10545-009-9020-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  30 in total

1.  Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells.

Authors:  S Miranda; R Foncea; J Guerrero; F Leighton
Journal:  Biochem Biophys Res Commun       Date:  1999-04-29       Impact factor: 3.575

Review 2.  Two direct repeats cause most human mtDNA deletions.

Authors:  David C Samuels; Eric A Schon; Patrick F Chinnery
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

3.  Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects.

Authors:  R Van Coster; J Smet; E George; L De Meirleir; S Seneca; J Van Hove; G Sebire; H Verhelst; J De Bleecker; B Van Vlem; P Verloo; J Leroy
Journal:  Pediatr Res       Date:  2001-11       Impact factor: 3.756

4.  Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA.

Authors:  Joél Smet; Sara Seneca; Boel De Paepe; Ann Meulemans; Helene Verhelst; Jules Leroy; Linda De Meirleir; Willy Lissens; Rudy Van Coster
Journal:  Electrophoresis       Date:  2009-10       Impact factor: 3.535

5.  Simultaneous detection and quantification of mitochondrial DNA deletion(s), depletion, and over-replication in patients with mitochondrial disease.

Authors:  Ren-Kui Bai; Lee-Jun C Wong
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

Review 6.  MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review.

Authors:  B C Chu; S Terae; C Takahashi; Y Kikuchi; K Miyasaka; S Abe; K Minowa; T Sawamura
Journal:  Neuroradiology       Date:  1999-10       Impact factor: 2.804

Review 7.  White matter involvement in mitochondrial diseases.

Authors:  Tally Lerman-Sagie; Esther Leshinsky-Silver; Nathan Watemberg; Yehudit Luckman; Dorit Lev
Journal:  Mol Genet Metab       Date:  2004-12-10       Impact factor: 4.797

Review 8.  Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies.

Authors:  Maria Cristina Bianchi; Giuseppina Sgandurra; Michela Tosetti; Roberta Battini; Giovanni Cioni
Journal:  Biosci Rep       Date:  2007-06       Impact factor: 3.840

9.  Mass spectrometric identification of mitochondrial oxidative phosphorylation subunits separated by two-dimensional blue-native polyacrylamide gel electrophoresis.

Authors:  Bart Devreese; Frank Vanrobaeys; Joél Smet; Jozef Van Beeumen; Rudy Van Coster
Journal:  Electrophoresis       Date:  2002-08       Impact factor: 3.535

10.  MR of the brain in mitochondrial myopathy.

Authors:  S H Wray; J M Provenzale; D R Johns; K R Thulborn
Journal:  AJNR Am J Neuroradiol       Date:  1995-05       Impact factor: 3.825

View more
  5 in total

1.  Complex III staining in blue native polyacrylamide gels.

Authors:  Joél Smet; Boel De Paepe; Sara Seneca; Willy Lissens; Heike Kotarsky; Linda De Meirleir; Vineta Fellman; Rudy Van Coster
Journal:  J Inherit Metab Dis       Date:  2011-04-12       Impact factor: 4.982

2.  Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency.

Authors:  Elise Vantroys; Joél Smet; Arnaud V Vanlander; Sarah Vergult; Ruth De Bruyne; Frank Roels; Hedwig Stepman; Herbert Roeyers; Björn Menten; Rudy Van Coster
Journal:  Orphanet J Rare Dis       Date:  2018-05-21       Impact factor: 4.123

3.  Clinical Heterogeneity in MT-ATP6 Pathogenic Variants: Same Genotype-Different Onset.

Authors:  Sara Capiau; Joél Smet; Boel De Paepe; Yilmaz Yildiz; Mutluay Arslan; Olivier Stevens; Maxime Verschoore; Hedwig Stepman; Sara Seneca; Arnaud Vanlander
Journal:  Cells       Date:  2022-01-30       Impact factor: 6.600

4.  Clinical, biochemical, and genetic spectrum of seven patients with NFU1 deficiency.

Authors:  Uwe Ahting; Johannes A Mayr; Arnaud V Vanlander; Steven A Hardy; Saikat Santra; Christine Makowski; Charlotte L Alston; Franz A Zimmermann; Lucia Abela; Barbara Plecko; Marianne Rohrbach; Stephanie Spranger; Sara Seneca; Boris Rolinski; Angela Hagendorff; Maja Hempel; Wolfgang Sperl; Thomas Meitinger; Joél Smet; Robert W Taylor; Rudy Van Coster; Peter Freisinger; Holger Prokisch; Tobias B Haack
Journal:  Front Genet       Date:  2015-04-13       Impact factor: 4.599

5.  Synteny-based analyses indicate that sequence divergence is not the main source of orphan genes.

Authors:  Nikolaos Vakirlis; Anne-Ruxandra Carvunis; Aoife McLysaght
Journal:  Elife       Date:  2020-02-18       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.